← Back
$RLMD All transactions

RELMADA THERAPEUTICS, INC.

▲ BUY
9 / 10

Conviction

$ Value

$86K

Shares

200,000

Price

$0

Filed

May 20

Why this score? (9/10)
  • Open market buy (+3)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Cluster: 4 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Kelly Paul Edward

Title

Chief Operating Officer

CIK

0001658544

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-16

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

412,295

Footnotes

The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range. | Purchase prices range from $0.4071 to $0.4498 per share, inclusive.

Filing Info

Accession No.

0001213900-25-046088

Form Type

4

Issuer CIK

0001553643

Kelly Paul Edward's History

Date Ticker Type Value
2025-12-12 RLMD A $0
2025-11-05 RLMD $198K
2025-06-26 RLMD A $0
2025-05-16 RLMD $86K

Other Insiders at RLMD (90d)

No other insider activity at this issuer in the last 90 days.